Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL23859934

N.Nc1ccc(OCc2ccccn2)c(Cl)c1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SYK P43405 3/20 0.76
ERBB2 P04626 10/20 0.51
EGFR P00533 8/20 0.51
ERBB3 P21860 1/20 0.51
ERBB4 Q15303 1/20 0.51
AURKA O14965 1/20 0.47
RPS6KB1 P23443 1/20 0.47
SLC6A4 P31645 1/20 0.47
LCK P06239 1/20 0.46
KMO O15229 1/20 0.44
AURKB Q96GD4 1/20 0.44
INCENP Q9NQS7 1/20 0.44
ABCB1 P08183 1/20 0.43
HTR1A P08908 1/20 0.43
DRD2 P14416 1/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
P2RX4 Q99571 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638125 0.98 SYK (0.78) SYKERBB2EGFRERBB3ERBB4
SCHEMBL159323 0.98 SYK (0.78) SYKERBB2EGFRERBB3ERBB4
Hydrochloric Acid SCHEMBL6239858 0.97 SYK (0.76) SYKERBB2EGFRERBB3ERBB4
SCHEMBL17601189 0.87 SYK (1.00) SYKERBB2EGFRERBB3ERBB4
SCHEMBL30623239 0.87 SYK (1.00) SYKERBB2EGFRERBB3ERBB4
SCHEMBL27097004 0.84 SYK (0.58) SYKERBB2EGFRERBB3ERBB4
SCHEMBL30729948 0.84 SYK (0.58) SYKERBB2EGFRERBB3ERBB4
SCHEMBL21340419 0.82 SYK (0.58) SYKERBB2EGFRERBB3ERBB4
SCHEMBL29568574 0.82 SYK (0.58) SYKERBB2EGFRERBB3ERBB4
SCHEMBL4028096 0.81 SYK (0.54) SYKERBB2EGFRERBB3ERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195206-A1 POLYMORPHIC FORMS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2021-09-30 WO disclosed